Development and validation of a high throughput whole blood thrombolysis plate assay

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Bonnard, T ^a,b   Law, L S ^b   Tennant, Z ^a,b   Hagemeyer, C E ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

BLOOD; DEVICES; FIBRINOLYSIS; HIGH THROUGHPUT SCREENING; HUMAN; KINETICS; METABOLISM; PROCEDURES; REPRODUCIBILITY; THROMBOSIS; TIME FACTOR; VALIDATION STUDY;

FIBRINOLYSIN; FIBRINOLYSIS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; KINETICS; REPRODUCIBILITY OF RESULTS; THROMBOSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 85019888960     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-02498-2     Document Type: Article

References (51)

1. White, H. D. & Chew, D. P. Acute myocardial infarction. Lancet (London, England) 372, 570-584, doi: 10.1016/s0140-6736(08)61237-4 (2008).
2. Millan, M., Dorado, L. & Davalos, A. Fibrinolytic therapy in acute stroke. Current cardiology reviews 6, 218-226, doi: 10.2174/157340310791658758 (2010).
3. Verhamme, P. et al. Catheter-directed thrombolysis with microplasmin for acute peripheral arterial occlusion (PAO): An exploratory study. International angiology: A journal of the International Union of Angiology 31, 289-296 (2012).
4. Marder, V. J. et al. Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results. Journal of thrombosis and haemostasis: JTH 10, 985-991, doi: 10.1111/j.1538-7836.2012.04728.x (2012).
5. Heiss, W. D. et al. Tissue at risk of infarction rescued by early reperfusion: A positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 18, 1298-1307, doi: 10.1097/00004647-199812000-00004 (1998).
6. Gurewich, V. Thrombolysis: A Critical First-Line Therapy with an Unfulfilled Potential. The American journal of medicine, doi: 10.1016/j.amjmed.2015.11.033 (2015).
7. Prasad, S. et al. Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thromb J 4, 14, doi: 10.1186/1477-9560-4-14 (2006).
8. Whiting, D. & DiNardo, J. A. TEG and ROTEM: Technology and clinical applications. American journal of hematology 89, 228-232, doi: 10.1002/ajh.23599 (2014).
9. Hartert, H. Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren. Klinische Wochenschrift 26, 577-583 (1948).
10. Tynngård, N., Lindahl, T. L. & Ramström, S. Assays of different aspects of haemostasis-what do they measure? Thrombosis Journal 13, 8, doi: 10.1186/s12959-015-0036-2 (2015).
11. Kowalski, E., Kopec, M. & Niewiarowski. An evaluation of the euglobulin method for the determination of fibrinolysis. Journal of clinical pathology 12, 215-218 (1959).
12. He, S., Bremme, K. & Blomback, M. A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results. Thrombosis research 96, 145-156 (1999).
13. Smith, A. A., Jacobson, L. J., Miller, B. I., Hathaway, W. E. & Manco-Johnson, M. J. A new euglobulin clot lysis assay for global fibrinolysis. Thrombosis research 112, 329-337, doi: 10.1016/j.thromres.2004.01.001 (2003).
14. Urano, T. et al. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1. Thrombosis and haemostasis 63, 82-86 (1990).
15. Weisel, J. W. & Litvinov, R. I. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate. Cardiovascular & hematological agents in medicinal chemistry 6, 161-180 (2008).
16. Brogren, H. et al. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 104, 3943-3948, doi: 10.1182/blood-2004-04-1439 (2004).
17. Varju, I. et al. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment. Thrombosis and haemostasis 113, 1289-1298, doi: 10.1160/th14-08-0669 (2015).
18. Wohner, N. Role of cellular elements in thrombus formation and dissolution. Cardiovascular & hematological agents in medicinal chemistry 6, 224-228 (2008).
19. Cines, D. B. et al. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood 123, 1596-1603, doi: 10.1182/blood-2013-08-523860 (2014).
20. Gersh, K. C., Nagaswami, C. & Weisel, J. W. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. Thrombosis and haemostasis 102, 1169-1175, doi: 10.1160/th09-03-0199 (2009).
21. Tutwiler, V. et al. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood. Blood 127, 149-159, doi: 10.1182/blood-2015-05-647560 (2016).
22. Stalker, T. J. et al. A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity. Blood 124, 1824-1831, doi: 10.1182/blood-2014-01-550319 (2014).
23. Longstaff, C. & Kolev, K. Basic mechanisms and regulation of fibrinolysis. Journal of thrombosis and haemostasis: JTH 13(Suppl 1), S98-105, doi: 10.1111/jth.12935 (2015).
24. Mutch, N. J., Thomas, L., Moore, N. R., Lisiak, K. M. & Booth, N. A. TAFIa, PAI-1 and alpha-Antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots. Journal of thrombosis and haemostasis: JTH 5, 812-817, doi: 10.1111/j.1538-7836.2007.02430.x (2007).
25. Sutton, J. T., Ivancevich, N. M., Perrin, S. R. Jr., Vela, D. C. & Holland, C. K. Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model. Ultrasound in medicine & biology 39, 813-824, doi: 10.1016/j.ultrasmedbio.2012.12.008 (2013).
26. Holland, C. K., Vaidya, S. S., Datta, S., Coussios, C. C. & Shaw, G. J. Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model. Thrombosis research 121, 663-673, doi: 10.1016/j.thromres.2007.07.006 (2008).
27. Chapin, J. C. & Hajjar, K. A. Fibrinolysis and the control of blood coagulation. Blood reviews 29, 17-24, doi: 10.1016/j.blre.2014.09.003 (2015).
28. Collen, D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thrombosis and haemostasis 43, 77-89 (1980).
29. Gunawan, S. T. et al. Multifunctional Thrombin-Activatable Polymer Capsules for Specific Targeting to Activated Platelets. Advanced materials (Deerfield Beach, Fla.) 27, 5153-5157, doi: 10.1002/adma.201502243 (2015).
30. Bonnard, T. et al. Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa. Journal of the American Heart Association 6, doi: 10.1161/jaha.116.004535 (2017).
31. Genet, G. F., Ostrowski, S. R., Sorensen, A. M. & Johansson, P. I. Detection of tPA-induced hyperfibrinolysis in whole blood by RapidTEG, KaolinTEG, and functional fibrinogenTEG in healthy individuals. Clinical and applied thrombosis/hemostasis: official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 18, 638-644, doi: 10.1177/1076029611434527 (2012).
32. Chapman, M. P. et al. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. The journal of trauma and acute care surgery 80, 16-23, discussion 23-15, doi: 10.1097/ta.0000000000000885 (2016).
33. Xin, K. Z., Chang, W. C. & Ovanesov, M. V. Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma. Thrombosis research 140, 132-139, doi: 10.1016/j.thromres.2015.11.023 (2016).
34. Lijnen, H. R. & Collen, D. Mechanisms of physiological fibrinolysis. Bailliere's clinical haematology 8, 277-290 (1995).
35. de Witt, S. M., Verdoold, R., Cosemans, J. M. & Heemskerk, J. W. Insights into platelet-based control of coagulation. Thrombosis research 133(Suppl 2), S139-148, doi: 10.1016/s0049-3848(14)50024-2 (2014).
36. Muthard, R. W. & Diamond, S. L. Blood clots are rapidly assembled hemodynamic sensors: Flow arrest triggers intraluminal thrombus contraction. Arteriosclerosis, thrombosis, and vascular biology 32, 2938-2945, doi: 10.1161/ATVBAHA.112.300312 (2012).
37. Fraser, S. R., Booth, N. A. & Mutch, N. J. The antifibrinolytic function of factor XIII is exclusively expressed through alpha(2)-Antiplasmin cross-linking. Blood 117, 6371-6374, doi: 10.1182/blood-2011-02-333203 (2011).
38. Dickneite, G. et al. Coagulation factor XIII: A multifunctional transglutaminase with clinical potential in a range of conditions. Thrombosis and haemostasis 113, 686-697, doi: 10.1160/th14-07-0625 (2015).
39. Mitchell, J. L. & Mutch, N. J. Novel aspects of platelet factor XIII function. Thrombosis research 141(Suppl 2), S17-21, doi: 10.1016/s0049-3848(16)30356-5 (2016).
40. Nilsson, C. U., Tynngard, N., Reinstrup, P. & Engstrom, M. Monitoring fibrinolysis in whole blood by viscoelastic instruments: A comparison of ROTEM and ReoRox. Scandinavian journal of clinical and laboratory investigation 73, 457-465, doi: 10.3109/00365513.2013.801509 (2013).
41. Solomon, C., Schochl, H., Ranucci, M., Schott, U. & Schlimp, C. J. Comparison of fibrin-based clot elasticity parameters measured by free oscillation rheometry (ReoRox (R)) versus thromboelastometry (ROTEM (R). Scandinavian journal of clinical and laboratory investigation 75, 239-246, doi: 10.3109/00365513.2014.993698 (2015).
42. Thomas, O., Larsson, A., Tynngard, N. & Schott, U. Thromboelastometry versus free-oscillation rheometry and enoxaparin versus tinzaparin: An in-vitro study comparing two viscoelastic haemostatic tests' dose-responses to two low molecular weight heparins at the time of withdrawing epidural catheters from ten patients after major surgery. BMC anesthesiology 15, 170, doi: 10.1186/s12871-015-0145-2 (2015).
43. Boudjeltia, K. Z. et al. A new device for measurement of fibrin clot lysis: Application to the euglobulin clot lysis time. BMC biotechnology 2, 8 (2002).
44. Paul-Brent, P. A., Cattley, T. N., Myers, S. P., Brooks, L. & Cheras, P. A. A rapid microtitre plate screening method for in vitro assessment of fibrinolysis: A preliminary report. Blood coagulation & fibrinolysis: An international journal in haemostasis and thrombosis 15, 273-278 (2004).
45. Kashuk, J. L. et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Annals of surgery 251, 604-614, doi: 10.1097/SLA.0b013e3181d3599c (2010).
46. Hunt, H. et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. The Cochrane database of systematic reviews 2, Cd010438, doi: 10.1002/14651858.CD010438.pub2 (2015).
47. Grunewald, M. et al. Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia. Haemophilia: The official journal of the World Federation of Hemophilia 8, 768-775 (2002).
48. Hartmann, M., Szalai, C. & Saner, F. H. Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment. World journal of gastroenterology 22, 1541-1550, doi: 10.3748/wjg.v22.i4.1541 (2016).
49. Salat, C. et al. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Bone marrow transplantation 14, 747-750 (1994).
50. Campello, E. et al. Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke. Thrombosis and haemostasis 115, doi: 10.1160/th15-10-0798 (2016).
51. Theusinger, O. M., Nurnberg, J., Asmis, L. M., Seifert, B. & Spahn, D. R. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. European journal of cardio-Thoracic surgery: official journal of the European Association for Cardio-Thoracic Surgery 37, 677-683, doi: 10.1016/j.ejcts.2009.07.038 (2010).